Business Wire·Dec 13, 2025, 10:57 AM ET

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock granted inducement equity awards totaling 7,800 shares to two newly hired employees.
The awards include stock options for 4,457 shares & restricted stock units (RSUs) for 3,343 shares.
The options have an exercise price of $45.25, based on the closing price on December 8, 2025.
Stock option vesting includes 25% on the first anniversary of the start date, with the remaining 75% vesting in 12 equal quarterly installments.
RSU vesting occurs in four equal annual installments, subject to continued service.
All grants were made under the 2022 Inducement Equity Plan, which applies only to new hires or those returning after a bona fide non-employment period.
Scholar Rock is a late-stage biopharmaceutical company developing apitegromab for spinal muscular atrophy & other neuromuscular diseases.